AU2001245987A1 - Compositions and methods for gene therapy - Google Patents

Compositions and methods for gene therapy

Info

Publication number
AU2001245987A1
AU2001245987A1 AU2001245987A AU4598701A AU2001245987A1 AU 2001245987 A1 AU2001245987 A1 AU 2001245987A1 AU 2001245987 A AU2001245987 A AU 2001245987A AU 4598701 A AU4598701 A AU 4598701A AU 2001245987 A1 AU2001245987 A1 AU 2001245987A1
Authority
AU
Australia
Prior art keywords
compositions
methods
gene therapy
therapy
gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001245987A
Inventor
Egisto Boschetti
Jean-Marie Vogel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biosphere Medical Inc
Original Assignee
Biosphere Medical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biosphere Medical Inc filed Critical Biosphere Medical Inc
Publication of AU2001245987A1 publication Critical patent/AU2001245987A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1658—Proteins, e.g. albumin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
AU2001245987A 2000-03-24 2001-03-23 Compositions and methods for gene therapy Abandoned AU2001245987A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19190200P 2000-03-24 2000-03-24
US60191902 2000-03-24
PCT/US2001/009618 WO2001072280A2 (en) 2000-03-24 2001-03-23 Microspheres for gene therapy

Publications (1)

Publication Number Publication Date
AU2001245987A1 true AU2001245987A1 (en) 2001-10-08

Family

ID=22707377

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001245987A Abandoned AU2001245987A1 (en) 2000-03-24 2001-03-23 Compositions and methods for gene therapy

Country Status (2)

Country Link
AU (1) AU2001245987A1 (en)
WO (1) WO2001072280A2 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7332160B2 (en) 2002-07-12 2008-02-19 Boston Scientific Scimed, Inc. Medical device and method for tissue removal and repair
US20060069168A1 (en) * 2002-10-29 2006-03-30 Norikazu Tabata Vascular embolization material
FR2858628B1 (en) * 2003-08-04 2008-01-04 Polyplus Transfection NOVEL NUCLEIC ACID COMPLEXES FOR RNA INTERFERENCE AND THEIR USE FOR INHIBITING PROTEIN EXPRESSION
US8821859B2 (en) * 2004-05-19 2014-09-02 Agency For Science, Technology And Research Methods and articles for the delivery of therapeutic agents
DE602005027862D1 (en) 2004-10-07 2011-06-16 Du Pont POLYMER BASED ON POLYSACCHARIDE FOR TISSUE ADHESIVES FOR MEDICAL USE
EP1844772A1 (en) * 2006-04-06 2007-10-17 Polyplus-Transfection SA Compositions for transfection of oligonucleotides active for gene silencing and their biological and therapeutical applications
EP2099845B1 (en) 2006-11-27 2020-12-23 Actamax Surgical Materials LLC Multi-functional polyalkylene oxides, hydrogels and tissue adhesives
WO2009029443A2 (en) * 2007-08-24 2009-03-05 E. I. Du Pont De Nemours And Company Method for embolization using liquid embolic materials
US8426492B2 (en) 2007-11-14 2013-04-23 Actamax Surgical Materials, Llc Oxidized cationic polysaccharide-based polymer tissue adhesive for medical use
US8551136B2 (en) 2008-07-17 2013-10-08 Actamax Surgical Materials, Llc High swell, long-lived hydrogel sealant
WO2010017215A2 (en) * 2008-08-04 2010-02-11 The Regents Of The University Of California Biodegradable microspheres and methods of use thereof
WO2010059279A2 (en) 2008-11-19 2010-05-27 E. I. Du Pont De Nemours And Company Hydrogel tissue adhesive formed from aminated polysaccharide and aldehyde-functionalized multi-arm polyether
US8466327B2 (en) 2008-11-19 2013-06-18 Actamax Surgical Materials, Llc Aldehyde-functionalized polyethers and method of making same
US8951989B2 (en) 2009-04-09 2015-02-10 Actamax Surgical Materials, Llc Hydrogel tissue adhesive having reduced degradation time
US8580950B2 (en) 2009-07-02 2013-11-12 Actamax Surgical Materials, Llc Aldehyde-functionalized polysaccharides
US8580951B2 (en) 2009-07-02 2013-11-12 Actamax Surgical Materials, Llc Aldehyde-functionalized polysaccharides
US9758606B2 (en) 2012-07-31 2017-09-12 The Trustees Of Columbia University In The City Of New York Cyclopropenium polymers and methods for making the same
US8859705B2 (en) 2012-11-19 2014-10-14 Actamax Surgical Materials Llc Hydrogel tissue adhesive having decreased gelation time and decreased degradation time
WO2015017340A2 (en) 2013-07-29 2015-02-05 Actamax Surgical Materials, Llc Low swell tissue adhesive and sealant formulations
GB201315321D0 (en) 2013-08-28 2013-10-09 Koninklijke Nederlandse Akademie Van Wetenschappen Transduction Buffer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2676927B1 (en) * 1991-05-29 1995-06-23 Ibf MICROSPHERES FOR USE IN THERAPEUTIC VASCULAR OCCLUSIONS AND INJECTABLE SOLUTIONS CONTAINING THEM.
DE69435342D1 (en) * 1993-07-19 2011-05-05 Angiotech Pharm Inc Anti-angiogenic agents and methods of use
WO1996011671A1 (en) * 1994-10-12 1996-04-25 Focal, Inc. Targeted delivery via biodegradable polymers
US6210707B1 (en) * 1996-11-12 2001-04-03 The Regents Of The University Of California Methods of forming protein-linked lipidic microparticles, and compositions thereof

Also Published As

Publication number Publication date
WO2001072280A2 (en) 2001-10-04
WO2001072280A3 (en) 2002-01-31

Similar Documents

Publication Publication Date Title
AU2001280968A1 (en) Compositions and methods for directed gene assembly
AU2625501A (en) Compositions and methods for gene silencing
AU2001285143A1 (en) Methods and compositions for targeted delivery
AU2002357119A1 (en) Mitocidal compositions and methods
AUPQ899700A0 (en) Probiotic recolonisation therapy
AU2002332020A1 (en) Compositions for oral gene therapy and methods of using same
AU2001253255A1 (en) Compositions and methods for inhibiting gene expression
AU2001245987A1 (en) Compositions and methods for gene therapy
AU2001280599A1 (en) Compounds and methods
AU2001253418A1 (en) Compounds and methods
AU2001271720A1 (en) Methods and compositions for determining gene function
AU5326100A (en) Pharmaceutical compositions and methods for use
AU2002364708A1 (en) Novel compositions and methods for cancer
AU2001243394A1 (en) Compounds and methods
AU2001238485A1 (en) Methods and compositions for gene delivery
AU2002357748A1 (en) Osteopontin-related compositions and methods
AU2001251138A1 (en) Compositions and methods for tissue specific gene regulation therapy
AU6094200A (en) Nor gene compositions and methods for use thereof
AU2756301A (en) Compositions comprising genome segments and methods of using the same
AU2002337943A1 (en) Novel compositions and methods for cancer
AU2002366809A1 (en) Syn3 compositions and methods
AU2001278951A1 (en) Compounds and methods
AU2001283226A1 (en) Methods and compositions for inhibiting rad51
AU2001285743A1 (en) Adipose-related gene
AU2001268053A1 (en) Human sparc-homologous (hsparc-h1) gene and methods and uses thereof